BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25484390)

  • 41. [Necrotizing hand-foot skin reaction induced by antiangiogenic in a patient with Thevenard neuroacropathy].
    Durant C; Saint-Jean M; Connault J; Pistorius MA; Planchon B
    J Mal Vasc; 2009 May; 34(3):222-5. PubMed ID: 19359111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous drug eruptions associated with the use of new oncological drugs.
    Belloni B; Schönewolf N; Rozati S; Goldinger SM; Dummer R
    Chem Immunol Allergy; 2012; 97():191-202. PubMed ID: 22613863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.
    Masini C; Sabbatini R; Porta C; Procopio G; Di Lorenzo G; Onofri A; Buti S; Iacovelli R; Invernizzi R; Moscetti L; Aste MG; Pagano M; Grosso F; Lucia Manenti A; Ortega C; Cosmai L; Del Giovane C; Conte PF
    BJU Int; 2012 Sep; 110(5):692-8. PubMed ID: 22364110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.
    Autier J; Escudier B; Wechsler J; Spatz A; Robert C
    Arch Dermatol; 2008 Jul; 144(7):886-92. PubMed ID: 18645140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin reactions to the new biologic anticancer drugs.
    Myskowski PL; Halpern AC
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):294-9. PubMed ID: 19797958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sorafenib and sunitinib: A dermatologist's perspective.
    Pragasam V; Verma R; Vasudevan B
    Indian Dermatol Online J; 2014 Jan; 5(1):1-3. PubMed ID: 24616845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrodactaly of both hands and foot associated with cutaneous hemangiomata: A case report with review of the literature.
    Fouda M; Sulimani RA
    Ann Saudi Med; 1993 Mar; 13(2):194-6. PubMed ID: 17588029
    [No Abstract]   [Full Text] [Related]  

  • 48. Macrodactyly of both hands and foot associated with cutaneous hemangiomata: A case report with review of the literature.
    Viljoen D
    Ann Saudi Med; 1994 Sep; 14(5):426. PubMed ID: 17587942
    [No Abstract]   [Full Text] [Related]  

  • 49. Reply: Macrodactyly of both hands and foot associated with cutaneous hemangiomata: A case report with review of the literature.
    Fouda M
    Ann Saudi Med; 1994 Sep; 14(5):426. PubMed ID: 17586962
    [No Abstract]   [Full Text] [Related]  

  • 50. Sorafenib Induced Hand-Foot Skin Reaction at Low Dose.
    Shah VH; Supekar BB; Singh RP; Mukhi JI
    Indian Dermatol Online J; 2020; 11(6):997-1000. PubMed ID: 33344356
    [No Abstract]   [Full Text] [Related]  

  • 51. DHA-mediated regulation of lung cancer cell migration is not directly associated with Gelsolin or Vimentin expression.
    Ali M; Heyob K; Rogers LK
    Life Sci; 2016 Jun; 155():1-9. PubMed ID: 27157519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
    McLellan B; Kerr H
    Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).
    Anderson R; Jatoi A; Robert C; Wood LS; Keating KN; Lacouture ME
    Oncologist; 2009 Mar; 14(3):291-302. PubMed ID: 19276294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lacouture ME; Wu S; Robert C; Atkins MB; Kong HH; Guitart J; Garbe C; Hauschild A; Puzanov I; Alexandrescu DT; Anderson RT; Wood L; Dutcher JP
    Oncologist; 2008 Sep; 13(9):1001-11. PubMed ID: 18779536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent hand-foot skin reaction and hair depigmentation with sunitinib: report of a case and literature review of kinase inhibitors and blocking antibodies.
    Bansal S; Sardana K; Singh K; Garg VK
    Indian J Dermatol; 2014 Nov; 59(6):588-91. PubMed ID: 25484390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hand-Foot Skin Reaction with Sunitinib: A Rare Case Report with Review of Literature.
    Das S; Roy AK; Barman S; Roy A
    Indian J Dermatol; 2020; 65(6):522-525. PubMed ID: 33487712
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.